medicines access
Two billion people still lack medicines access. Is the industry doing enough?
December 22, 2015Manufacturing and Production Access to Medicine Foundation, Access to Medicine Index, affordability, market access, medicines access, pricing
“We have a mission to encourage the pharmaceutical industry in improving access to medicine for the two billion people who …
Medicines Patent Pool to include hep C and TB drugs
November 9, 2015Sales and Marketing Medicines Patent Pool, affordable drugs, hep C, hepatitis, hepatitis C, medicines access, tuberculosis
The Medicines Patent Pool has expanded to include a mandate to make treatments for hepatitis C and tuberculosis affordable and …
EMA launches scheme to prioritise medicines access for patients
October 27, 2015Manufacturing and Production EMA, European Medicines Agency, medicines access
The EMA has launched a public consultation on a scheme which aims to enable access to more medicines.The PRIME scheme …
Don’t replace NICE with another ‘misguided experiment’
November 5, 2010Sales and Marketing NHS, NICE, Stockholm Network, medicines access, risk-sharing
Replacing NICE with a similar system would be detrimental to UK healthcare, according to the Stockholm Network, which further warns …
GSK tops access to medicines ranking
June 21, 2010Sales and Marketing GlaxoSmithKline, developing world, medicines access
GlaxoSmithKline does the most of any pharma manufacturer to improve access to medicines needed in the developing world, according to …
The Pharmafocus Interview: David Gillen
February 3, 2009Research and Development Pfizer, UK, medicines access
David Gillen says he is a born optimist. But Pfizer UK’s medical director says this positive outlook doesn’t blind him …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
